4
Changes in Ownership
Roivant Sciences Ltd. Filed Acc 0001140361-26-036246
Director sold 20,000 shares at $39.90 ($798,000)
- Director acquired 20,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fitzgerald Meghan Director | 2026-09-08 | Option exercise 10b5-1 | +20,000 | $8.80 | $176,000 | 62,963 | D |
| Fitzgerald Meghan Director | 2026-09-08 | Sale 10b5-1 | −20,000 | $39.90 | $798,000 | 42,963 | D |
| Derivatives | |||||||
| Fitzgerald Meghan Director | 2026-09-08 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 18,578 | D | ||
| Open-market sales · 20,000 sh · avg $39.90 · $798,000 | |||||||
Loading xslF345X06/form4.xml…